Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R)

Synonyms: GSK 3772847; CNTO-7160

Melrilimab (anti-IL-1RL1/ ST2 / IL-33R) is an anti-ST2 (IL-1RL) monoclonal antibody targeting the IL-33 receptor. Melrilimab has the potential to be used in asthma research. MW: 145.2 KD.

Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Melrilimab (anti-IL-1RL1/ ST2 / IL-33R) is an anti-ST2 (IL-1RL) monoclonal antibody targeting the IL-33 receptor. Melrilimab has the potential to be used in asthma research. MW: 145.2 KD.

Product Details

CAS No. 2222865-46-3
Molecular Weight 145.2
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R) | Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R) supplier | purchase Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R) | Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R) cost | Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R) manufacturer | order Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R) | Melrilimab (Anti-IL-1RL1 / ST2 / IL-33R) distributor